Potential new strategy for advanced lung cancer
Slowing inflammation may boost immunotherapy’s effectiveness against advanced lung cancer High response rates for patients with stage 4 lung cancer after anti-inflammatory drug added temporarily to immune checkpoint inhibitor therapy PHILADELPHIA – Adding …